Fertilitätserhalt bei Krebspatientinnen – Welche Möglichkeiten gibt es?

Frauen, die mit der Diagnose einer Krebserkrankung konfrontiert werden, stellen sich zuallererst die Frage nach ihren Überlebenschancen. Heutzutage tritt aber auch das Leben nach der Therapie in den Vordergrund.

• Literatur

• 1 Mod. aus Sonmezer M, Oktay K. Fertility preservation in patients undegoing gonadotoxic treatment or gonadal resektion. UpToDate 2014;
• 2 Cobo A, Diaz C. Clinical application of oocyte vitrification: a sistematic review and meta-analysis of randomized controlled trials. Fertil Steril 2011; 96: 277-285
• 3 Barton SE, Missmer SA, Berry KF et al. Female cancer survivors are low responders and have reduced success compared with other patients undergoing reproductive technologies. Fertil Steril 2012; 97: 381-386
• 4 Porcu E, Venturoli S. Progress in oocyte cryopreservation. Curr Opin Obstet Gynecol 2006; 18: 273-273
• 5 Bastings L, Beerendonk CC, Westphal JR et al. Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. Hum Reprod Update 2013; 19: 483-506
• 6 Struewing JP, Hartge P, Wacholder S et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Askenazi Jews. N Engl J Med 1997; 336: 1401-1408
• 7 Wang C, Chen M, Fu F et al. Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis. PLoS One 2013; 49
• 8 Anderson B, LaPolla J, Turner D et al. Ovarian transposition in cervical cancer. Gynecol Oncol 1993; 49: 206-214